Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2019 Earnings Conference Call August 14, 2019 4:30 PM ET
Company Participants
Sabrina Martucci Johnson - President and Chief Executive Officer
Lisa Walters-Hoffert - Chief Financial Officer
Christine Mauck - Medical Director
David Friend - Chief Scientific Officer
John Fair - Chief Business Officer
Conference Call Participants
Yasmeen Rahimi - ROTH Capital Partners
Jason Kolbert - Dawson James Securities
Joanne Lee - Maxim Group LLC
James Molloy - Alliance Global Partners
Brian Marckx - Zacks Investments Research
Operator
Welcome to the conference call hosted by Daré Bioscience to discuss financial results for the quarter ended June 30, 2019, and to provide a general business update. This call is being recorded. My name is Joel, and I will be your operator today.
With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; Lisa Walters-Hoffert, Daré's Chief Financial Officer; Dr. Christine Mauck, Daré's Medical Director; and Dr. David Friend, Daré's Chief Scientific Officer.
Ms. Johnson, please proceed.
Sabrina Martucci Johnson
Thank you and welcome to our financial results and business update call for Daré Bioscience. It's a pleasure to have the opportunity to talk about our second quarter results and Company highlights as well as our upcoming milestones for the remainder of 2019 and 2020.
Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historic fact should be considered forward-looking statements.
Actual results or events could differ materially from those anticipated or implied by these statements due to known and unknown risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking
- Read more current DARE analysis and news
- View all earnings call transcripts